Vr Porn Sitesfree premium pornhottest pornpeçetekağıt poşet Dennison (dan) Veru | BioCancell Therapeutics  | Israel

Pathology Experts

Dennison (dan) Veru

BioCancell Therapeutics 


Mr. Veru has been the Chief Investment Officer (Institutional) of Palisade Capital Management, an asset manager with $3 billion under management, since 2000, with oversight responsibilities for all of Palisade’s investment strategies that trade publicly-traded securities. Mr. Veru previously held a variety of analytical positions at Drexel Burnham Lambert and later at Smith Barney. From 1992 through 1999, Mr. Veru was the President and Director of Research at Awad Asset Management and helped oversee the firm’s growth from start up to more than $1 billion of small-cap institutional and high net worth assets. Prior to Awad, Mr. Veru held a variety of analytical roles at Drexel Burnham Lambert and later at Smith Barney Harris Upham. In addition to his professional responsibilities, Mr. Veru is a member of the Board of Overseers of the St. Luke’s and Roosevelt hospital, a member of the finance committee of the Dwight-Englewood School, and a member of the Board of the McCarton School for autistic children. He is a frequent guest on CNBC, Bloomberg News, Fox News and CNN, and also contributes market opinions to various financial publications. Mr. Veru holds a B.A. in Government from Franklin & Marshall College.

Research Interest


Global Experts from Israel

Global Experts in Subject